The latest advances in the treatment of triple-negative breast cancer include combined chemotherapy and immunotherapy, which are yielding some encouraging results in the early stages of the disease, in first-line treatment, and in adjuvant and neoadjuvant treatment

Authors
Luis Teixeira, Hôpital Saint Louis, Paris, France
Authors
Luis Teixeira, Hôpital Saint Louis, Paris, France
Category
Oncology
Publication type
Proceedings
Year
2019
Download the publication